Cathepsin G deficiency reduces periaortic calcium chloride injury-induced abdominal aortic aneurysms in mice

Journal of Vascular Surgery

Volumn 62, Issue 6, 2015, Pages 1615-1624

  Wang, Jing ^a   Sukhova, Galina K ^a   Liu, Jian ^a   Ozaki, Keith ^a   Lesner, Adam ^b   Libby, Peter ^a   Kovanen, Petri T ^c   Shi, Guo Ping ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF GDA SK   (Poland)

^c WIHURI RESEARCH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CATHEPSIN G; DIPEPTIDYL CARBOXYPEPTIDASE; ELASTIN; GELATIN; GELATINASE A; GELATINASE B; LOW DENSITY LIPOPROTEIN RECEPTOR; SMALL INTERFERING RNA;

ABDOMINAL AORTA ANEURYSM; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA INJURY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; COLLAGEN DEGRADATION; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; ENZYME DEFICIENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOLOGY; IN VITRO STUDY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PERIAORTIC CALCIUM CHLORIDE INJURY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; ABDOMINAL AORTA; ANIMAL; BLOOD; DEFICIENCY; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SMOOTH MUSCLE CELL;

ANGIOTENSIN II; ANIMALS; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; CATHEPSIN G; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MICE; MYOCYTES, SMOOTH MUSCLE; PEPTIDYL-DIPEPTIDASE A;

EID: 84948710992     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2014.06.004     Document Type: Article

References (45)

1. S. Helske, S. Syväranta, M. Kupari, J. Lappalainen, M. Laine, J. Lommi, and et al. Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves Eur Heart J 27 2006 1495 1504
2. L.W. Heck, K.S. Rostand, F.A. Hunter, and A. Bhown Isolation, characterization, and amino-terminal amino acid sequence analysis of human neutrophil cathepsin G from normal donors Anal Biochem 158 1986 217 227
3. C.A. Owen, and E.J. Campbell Angiotensin II generation at the cell surface of activated neutrophils: novel cathepsin G-mediated catalytic activity that is resistant to inhibition J Immunol 160 1998 1436 1443
4. Y. Okada, and I. Nakanishi Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 ('gelatinase') by human neutrophil elastase and cathepsin G FEBS Lett 249 1989 353 356
5. W.B. Saunders, K.J. Bayless, and G.E. Davis MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices J Cell Sci 118 2005 2325 2340
6. T.J. Wilson, K.C. Nannuru, and R.K. Singh Cathepsin G-mediated activation of pro-matrix metalloproteinase 9 at the tumor-bone interface promotes transforming growth factor-beta signaling and bone destruction Mol Cancer Res 7 2009 1224 1233
7. P. Shamamian, J.D. Schwartz, B.J. Pocock, S. Monea, D. Whiting, S.G. Marcus, and et al. Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis J Cell Physiol 189 2001 197 206
8. A.C. Newby Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability Arterioscler Thromb Vasc Biol 28 2008 2108 2114
9. W.B. Keeling, P.A. Armstrong, P.A. Stone, D.F. Bandyk, and M.L. Shames An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms Vasc Endovascular Surg 39 2005 457 464
10. C. Capodici, G. Muthukumaran, M.A. Amoruso, and R.A. Berg Activation of neutrophil collagenase by cathepsin G Inflammation 13 1989 245 258
11. C.M. Kielty, M. Lees, C.A. Shuttleworth, and D. Woolley Catabolism of intact type VI collagen microfibrils: susceptibility to degradation by serine proteinases Biochem Biophys Res Commun 191 1993 1230 1236
12. C. Boudier, G. Godeau, W. Hornebeck, L. Robert, and J.G. Bieth The elastolytic activity of cathepsin G: an ex vivo study with dermal elastin Am J Respir Cell Mol Biol 4 1991 497 503
13. M.I. Mäyränpää, J.A. Trosien, V. Fontaine, M. Folkesson, M. Kazi, P. Eriksson, and et al. Mast cells associate with neovessels in the media and adventitia of abdominal aortic aneurysms J Vasc Surg 50 2009 388 395 discussion: 395-6
14. M. Gacko, and L. Chyczewski Activity and localization of cathepsin B, D and G in aortic aneurysm Int Surg 82 1997 398 402
15. T. Dejouvencel, D. Féron, P. Rossignol, M. Sapoval, C. Kauffmann, J.M. Piot, and et al. Hemorphin 7 reflects hemoglobin proteolysis in abdominal aortic aneurysm Arterioscler Thromb Vasc Biol 30 2010 269 275
16. Y. Wang, Y. Bai, L. Qin, P. Zhang, T. Yi, S.A. Teesdale, and et al. Interferon-gamma induces human vascular smooth muscle cell proliferation and intimal expansion by phosphatidylinositol 3-kinase dependent mammalian target of rapamycin raptor complex 1 activation Circ Res 101 2007 560 569
17. M. Sieńczyk, A. Lesner, M. Wysocka, A. Legowska, E. Pietrusewicz, K. Rolka, and et al. New potent cathepsin G phosphonate inhibitors Bioorg Med Chem 16 2008 8863 8867
18. D.M. MacIvor, S.D. Shapiro, C.T. Pham, A. Belaaouaj, S.N. Abraham, and T.J. Ley Normal neutrophil function in cathepsin G-deficient mice Blood 94 1999 4282 4293
19. G.M. Longo, W. Xiong, T.C. Greiner, Y. Zhao, N. Fiotti, and B.T. Baxter Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms J Clin Invest 110 2002 625 632
20. J. Sun, G.K. Sukhova, M. Yang, P.J. Wolters, L.A. MacFarlane, P. Libby, and et al. Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice J Clin Invest 117 2007 3359 3368
21. S. Kitamoto, G.K. Sukhova, J. Sun, M. Yang, P. Libby, V. Love, and et al. Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice Circulation 115 2007 2065 2075
22. R.J. Havel, H.A. Eder, and J.H. Bragdon The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum J Clin Invest 34 1955 1345 1353
23. G.K. Sukhova, G.P. Shi, D.I. Simon, H.A. Chapman, and P. Libby Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells J Clin Invest 102 1998 576 583
24. J.E. Kanter, F. Johansson, R.C. LeBoeuf, and K.E. Bornfeldt Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques? Circ Res 100 2007 769 781
25. 18F-fluorodeoxyglucose uptake in abdominal aortic aneurysms in positron emission/computed tomography is associated with inflammation, aortic wall instability, and acute symptoms J Vasc Surg 48 2008 417 423 discussion: 424
26. T. Tsuruda, K. Hatakeyama, S. Nagamachi, Y. Sekita, S. Sakamoto, G.J. Endo, and et al. Inhibition of development of abdominal aortic aneurysm by glycolysis restriction Arterioscler Thromb Vasc Biol 32 2012 1410 1417
27. E.N. Lavrentyev, A.M. Estes, and K.U. Malik Mechanism of high glucose induced angiotensin II production in rat vascular smooth muscle cells Circ Res 101 2007 455 464
28. G.K. Sukhova, Y. Zhang, J.H. Pan, Y. Wada, T. Yamamoto, M. Naito, and et al. Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice J Clin Invest 111 2003 897 906
29. R.J. Rizzo, W.J. McCarthy, S.N. Dixit, M.P. Lilly, V.P. Shively, W.R. Flinn, and et al. Collagen types and matrix protein content in human abdominal aortic aneurysms J Vasc Surg 10 1989 365 373
30. E.D. Son, H. Kim, H. Choi, S.H. Lee, J.Y. Lee, S. Kim, and et al. Cathepsin G increases MMP expression in normal human fibroblasts through fibronectin fragmentation, and induces the conversion of proMMP-1 to active MMP-1 J Dermatol Sci 53 2009 150 152
31. D. Wågsäter, D. Johansson, V. Fontaine, E. Vorkapic, A. Bäcklund, A. Razuvaev, and et al. Serine protease inhibitor A3 in atherosclerosis and aneurysm disease Int J Mol Med 30 2012 288 294
32. J.H. Lindeman, B.A. Ashcroft, J.W. Beenakker, M. van Es, N.B. Koekkoek, F.A. Prins, and et al. Distinct defects in collagen microarchitecture underlie vessel-wall failure in advanced abdominal aneurysms and aneurysms in Marfan syndrome Proc Natl Acad Sci U S A 107 2010 862 865
33. Y. Okada, Y. Gonoji, K. Naka, K. Tomita, I. Nakanishi, K. Iwata, and et al. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties J Biol Chem 267 1992 21712 21719
34. R.P. Mecham, T.J. Broekelmann, C.J. Fliszar, S.D. Shapiro, H.G. Welgus, and R.M. Senior Elastin degradation by matrix metalloproteinases. Cleavage site specificity and mechanisms of elastolysis J Biol Chem 272 1997 18071 18076
35. Yasmin, C.M. McEniery, S. Wallace, Z. Dakham, P. Pulsalkar, K. Maki-Petaja, and et al. Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness Arterioscler Thromb Vasc Biol 25 2005 372
36. T. Matsusaka, F. Niimura, A. Shimizu, I. Pastan, A. Saito, H. Kobori, and et al. Liver angiotensinogen is the primary source of renal angiotensin II J Am Soc Nephrol 23 2012 1181 1189
37. L.A. Cassis, M. Gupte, S. Thayer, X. Zhang, R. Charnigo, D.A. Howatt, and et al. ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice Am J Physiol Heart Circ Physiol 296 2009 H1660 H1665
38. E. Torsney, G. Pirianov, and G.W. Cockerill Diabetes as a negative risk factor for abdominal aortic aneurysm-does the disease aetiology or the treatment provide the mechanism of protection? Curr Vasc Pharmacol 11 2013 293 298
39. U. Kampmann, B. Christensen, T.S. Nielsen, S.B. Pedersen, L. ørskov, S. Lund, and et al. GLUT4 and UBC9 protein expression is reduced in muscle from type 2 diabetic patients with severe insulin resistance PLoS One 6 2011 e27854
40. S. Kouidhi, R. Berrhouma, K. Rouissi, S. Jarboui, M.S. Clerget-Froidevaux, I. Seugnet, and et al. Human subcutaneous adipose tissue Glut 4 mRNA expression in obesity and type 2 diabetes Acta Diabetol 50 2013 227 232
41. D. Kipmen-Korgun, S. Bilmen-Sarikcioglu, H. Altunbas, R. Demir, and E.T. Korgun Type-2 diabetes down-regulates glucose transporter proteins and genes of the human blood leukocytes Scand J Clin Lab Invest 69 2009 350 358
42. M. Gaster, P. Staehr, H. Beck-Nielsen, H.D. Schrøder, and A. Handberg GLUT4 is reduced in slow muscle fibers of type 2 diabetic patients: is insulin resistance in type 2 diabetes a slow, type 1 fiber disease? Diabetes 50 2001 1324 1329
43. G. Giacchetti, E. Faloia, A. Taccaliti, P.P. Morosini, G. Arnaldi, F. Soletti, and et al. Decreased expression of insulin-sensitive glucose transporter mRNA (GLUT-4) in adipose tissue of non-insulin-dependent diabetic and obese patients: evaluation by a simplified quantitative PCR assay J Endocrinol Invest 17 1994 709 715
44. T. Tao, Y. Tanizawa, A. Matsutani, A. Matsubara, T. Kaneko, and K. Kaku HepG2/erythrocyte glucose transporter (GLUT1) gene in NIDDM: a population association study and molecular scanning in Japanese subjects Diabetologia 38 1995 942 947
45. H. Lu, D.L. Rateri, L.A. Cassis, and A. Daugherty The role of the renin-angiotensin system in aortic aneurysmal diseases Curr Hypertens Rep 10 2008 99 106